ZS Pharma Seeks $150M In Secondary Offering

Fort Worth-based biopharmaceuticals firm ZS Pharma has filed for a secondary public offering, saying in a recent filing that it is looking to raised $150M in the offering, ten months after its successful IPO. The company did not detail other information on who would be selling the shares in the offering. ZS Pharma is listed on the Nasdaq Global Market as ZSPH. The company's venture backers are Alta Partners, Fidelity Investment, Devon Park Bioventures, 3x5 Special Opportunity Fund, and others. It's not unusual in the months after an IPO for a company's venture investors to look at offloading some of their shares; however, ZS Pharma did not indicate if this secondary will be for the company's own uses or to provide its early investors with some liquidity.